Account
B&K appoints Pitchfork Partners as its strategic communications counsel
Mumbai: B&K (Batlivala & Karani) has appointed Pitchfork Partners as its integrated communications partner.
After a competitive selection process, Pitchfork emerged as the agency of choice to develop and execute a comprehensive communications strategy for B&K. Under this mandate, Pitchfork will work towards enhancing the group’s external reach through strategic media relations, thought leadership and social media outreach.
Sharing his views on the appointment, Pitchfork Partners co-founder Jaideep Shergill said, “As our economy grows, the need for firms that understand money and can offer suitable research-backed counsel to institutions and individuals alike is also witnessing a mounting demand. B&K has been at the forefront of this for over 140 years and we at Pitchfork are thrilled to be their strategic communications partner. We are confident that our extensive experience in financial services communications will help the firm in driving impactful conversations across mediums.”
In response to the partnership, B&K group MD Saahil Murarka commented, “We are excited to kickstart our communications journey with Pitchfork Partners. Their proven track record and industry understanding approach align perfectly with our requirements as we aim to engage more effectively with our stakeholders.”
Established in the 1880s, B&K enjoys an undisputed legacy and has built a wide range of offerings with a special focus on equity capital markets and Wealth Services. The group’s current AUA exceeds Rs 50,000 crores.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
